Highlight Capital
Venture capitalNanjin · Seed–Series B
Investment thesis
Highlight Capital positions itself around professionalism, stability, and innovation, focusing on deep, long-term investing in China. Over more than ten years it has built a portfolio of over 200 companies, with a notable emphasis on healthcare and life sciences (biotech, pharmaceuticals) as suggested by recent portfolio activity. The firm has achieved 30+ IPOs, indicating a track record spanning early through later stages of company development in the Chinese market.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 15 of 37 portfolio companiesHealthtech ×10Biotech ×8Hardware ×7Medical Devices ×7Advanced Manufacturing ×3Deep Tech ×3Digital Health ×3Semiconductors ×3
HQs:China×7United States×3Singapore×1
Investments · 37 tracked
founders shown can be your intro pathBy year:2025 · 12017 · 12 dated
BiotechLaguna Hills, US
Litain Yeh(Executive Officer, Director, Promoter)inShunqi Yan(Executive Officer, Director, Promoter)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Co-investorsHM Venture Partners
Co-investorsOrbiMed
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsAmgen VenturesClarus VenturesFrazier Healthcare Partners
MCT manufactures satellite positioning and GNSS evaluation kits for automotive and robotics applications, featuring tri-band RTK receivers with automotive-grade certifications for operation in extreme temperatures.
AI & Machine LearningDeep TechHardwareRoboticsSemiconductorsChangzhou, CN
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesSingapore, SG
Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in
Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundClavystBioSEEDS Capital
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
Co-investors20/20 HealthCare Partners LLC
WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtech
Co-investorsHuangpu River CapitalVivo CapitalLegend Capital
Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
BiotechHealthtechMedical Devices
Julie Eastland(Chief Executive Officer and Director)in
BoardScott Myers(Chairperson)
Co-investorsDecheng Capital
Shanghai General Healthy Information & Technology develops intelligent medical logistics and automation equipment, including automated pharmacy dispensing systems marketed under the CONSIS and SANTO brands, for hospitals.
Digital HealthHardwareHealthtechRoboticsShanghai, CN
Co-investorsLAVLegend CapitalLilly Asia Ventures
Reached its first strategic alliance milestone with Deerfield, valued at over $1.6 billion.
Completed a Series C financing round of over RMB 200 million.
Co-investorsLAVLilly Asia Ventures
Co-investorsLAVGreen Pine Capital PartnersLilly Asia Ventures
Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.
Advanced ManufacturingBiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesBeijing, CN
楼柏良(董事长兼首席执行官 (Chairman & CEO))Lou Bailiang(Chemist, Chairman & CEO)
Co-investorsLegend Capital
Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments.
HardwareHealthtechMedical DevicesHangzhou, CN
Smoore is an atomization technology company that develops and manufactures vaping and electronic atomization devices.
Advanced ManufacturingHardware
Completed a Series A financing round of over RMB 500 million, invested in by Highlight.
Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices.
BiotechDigital HealthHealthtechMedical DevicesHangzhou, CN
Chinese fabless semiconductor company developing enterprise-grade interconnect chips, including PCIe interface chips, memory interface chips and buffers, network interface chips, and clock/general interface chips.
Deep TechHardwareSemiconductorsChengdu, CN
Co-investorsLegend Capital
Co-investorsLegend Capital
Completed a Series A financing round of around RMB 100 million.
Drug discovery services (01873.HK)
Pharmaceutical R&D services (603259.SH)
Completed a new round of financing.
Recommended to attend the Davos Forum.
Ophthalmic medical company (02407.HK)
Medical device company (002223.SZ)
KK Chips designs automotive semiconductor solutions including power management, driver, and control chips for 12V and 24V automotive systems used in electric vehicles, hybrid vehicles, and commercial vehicles.
HardwareMobility & TransportationSemiconductorsGuangzhou, CN
Portfolio news
latest coverage across their companies
Arthrosi Therapeutics · finance.yahoo.com · Oct 9, 2025
Imago · imagosystems.com · Sep 4, 2025
Nuevocor · precisionmedicineonline.com · May 9, 2025
Frequently asked questions
- How many investments has Highlight Capital made?
- Highlight Capital has 34 tracked investments.
- What stage does Highlight Capital invest at?
- Highlight Capital invests at the Seed, Series A, Series B stages.
- What is Highlight Capital's typical check size?
- Highlight Capital typically writes checks of $2.8M – $74M.
- What sectors does Highlight Capital focus on?
- Highlight Capital focuses on Biotech, Crypto & Web3, Healthtech.
- Where is Highlight Capital located?
- Highlight Capital is headquartered in Nanjin, CN.
- Who does Highlight Capital co-invest with?
- Highlight Capital most often shares deals with LAV, Decheng Capital, Huangpu River Capital, among 6 tracked co-investors.
Similar investors
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.



.jpeg)

